Chemed Corp. Stock
Price
Target price
€530.00
€530.00
-
-
-
€600.54
03.10.24 / Stuttgart Stock Exchange
WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Chemed Corp. Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Chemed Corp..
With a target price of 600 € there is a slightly positive potential of 13.21% for Chemed Corp. compared to the current price of 530.0 €.
So far the community has only identified positive things for Chemed Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Chemed Corp. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chemed Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemed Corp. | - | -0.935% | 0.952% | - | - | - | - |
| Amn Healthcare Svs | -1.140% | -6.486% | -26.383% | -57.805% | -48.358% | -64.694% | -29.960% |
| Ensign Group Inc. | 0.760% | 1.538% | -2.941% | 50.857% | 28.155% | - | - |
| Select Medical Holdings | 0.660% | 0.658% | -2.548% | 33.043% | 41.667% | -2.548% | 112.500% |
Comments
Chemed Co. (NYSE: CHE) had its price target lowered by analysts at Royal Bank of Canada from $712.00 to $697.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $604.00 to $712.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
News
Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2024, on Tuesday, October 29, 2024, following the close of trading on
Chemed Corporation Declares Quarterly Dividend of 50 Cents
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on August 30, 2024, to
Chemed Reports Second-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest